PAG1
Basic information
Region (hg38): 8:80967810-81112068
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (43 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PAG1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000018440.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 39 | 45 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 39 | 5 | 1 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PAG1 | protein_coding | protein_coding | ENST00000220597 | 6 | 144259 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0178 | 0.978 | 125733 | 0 | 15 | 125748 | 0.0000596 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.992 | 206 | 250 | 0.824 | 0.0000137 | 2841 |
| Missense in Polyphen | 64 | 89.131 | 0.71804 | 1059 | ||
| Synonymous | -0.0155 | 104 | 104 | 1.00 | 0.00000678 | 837 |
| Loss of Function | 2.52 | 6 | 17.3 | 0.347 | 8.15e-7 | 214 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000186 | 0.000185 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000528 | 0.0000527 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.0000980 | 0.0000980 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Negatively regulates TCR (T-cell antigen receptor)- mediated signaling in T-cells and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Promotes CSK activation and recruitment to lipid rafts, which results in LCK inhibition. Inhibits immunological synapse formation by preventing dynamic arrangement of lipid raft proteins. May be involved in cell adhesion signaling. {ECO:0000269|PubMed:10790433}.;
- Pathway
- Signal Transduction;Phosphorylation of CD3 and TCR zeta chains;TCR signaling;TCR;Immune System;Adaptive Immune System;Signaling by EGFR;SHP2 signaling;CXCR4-mediated signaling events;GAB1 signalosome;BCR signaling pathway;Signaling by Receptor Tyrosine Kinases;TCR signaling in naïve CD8+ T cells;PDGFR-beta signaling pathway;TCR signaling in naïve CD4+ T cells
(Consensus)
Recessive Scores
- pRec
- 0.143
Intolerance Scores
- loftool
- 0.174
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.76
Haploinsufficiency Scores
- pHI
- 0.313
- hipred
- Y
- hipred_score
- 0.553
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.425
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pag1
- Phenotype
- immune system phenotype; hematopoietic system phenotype; normal phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- adaptive immune response;signal transduction;positive regulation of signal transduction;intracellular signal transduction;T cell receptor signaling pathway;regulation of T cell activation;negative regulation of T cell activation
- Cellular component
- plasma membrane;integral component of membrane;membrane raft
- Molecular function
- SH3/SH2 adaptor activity;protein binding;SH2 domain binding